ARTV · Artiva Biotherapeutics, Inc.

Summary

Artiva Biotherapeutics, Inc. filed an 8-K on March 10, 2026, under Item 2.02 disclosing results of operations via Exhibit 99.1 Press Release, which is not deemed 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934. Item 9.01 lists the exhibits including the press release.

Key takeaways

• Item 2.02 triggered for results of operations disclosure.
• Exhibit 99.1 is Press Release dated March 10, 2026.
• Exhibit 104 is Cover Page Interactive Data File.
• Disclosure under Item 2.02 not deemed 'filed' under Section 18.